FDA limits acetaminophen in prescription combination products

被引：0
|
作者：
Laffman-Johnson, Elise
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：476 / 476
页数：1
相关论文
共 50 条
  • [1] ACETAMINOPHEN COMPLICATIONS BEFORE VS AFTER FDA MANDATE TO LIMIT ACETAMINOPHEN DOSE IN PRESCRIPTION COMBINATION OPIOID PRODUCTS
    Orandi, Babak
    McLeod, Chandler
    Lee, William M.
    Karvellas, Constantine J.
    McGuire, Brendan M.
    Lewis, Cora E.
    Terrault, Norah
    Locke, Jayme E.
    HEPATOLOGY, 2022, 76 : S1234 - S1234
  • [2] FDA acts to limit exposure to acetaminophen in combination products
    McCarthy, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [3] Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure
    Orandi, Babak J.
    McLeod, M. Chandler
    MacLennan, Paul A.
    Lee, William M.
    Fontana, Robert J.
    Karvellas, Constantine J.
    McGuire, Brendan M.
    Lewis, Cora E.
    Terrault, Norah M.
    Locke, Jayme E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (09): : 735 - 744
  • [4] Association of FDA Mandate Limiting Acetaminophen in Prescription Combination Opioid Products and Subsequent Hospitalizations, Acute Liver Failure, and Liver Transplant
    Orandi, B.
    McLeod, C.
    MacLennan, P.
    Lee, W.
    Fontana, R.
    Karvellas, C.
    McGuire, B.
    Lewis, C.
    Terrault, N.
    Locke, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S607 - S607
  • [5] Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products
    Goldberger D.
    Vearrier D.
    Journal of Medical Toxicology, 2017, 13 (4) : 303 - 308
  • [6] Mandating limits on acetaminophen in combination opioid products does not decrease incidence of hepatotoxicity
    Goldberger, David
    Vearrier, David
    CLINICAL TOXICOLOGY, 2016, 54 (08) : 768 - 768
  • [7] Comment on: Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products
    Mullins, Michael E.
    Dunn, S. Eliza
    JOURNAL OF MEDICAL TOXICOLOGY, 2018, 14 (01) : 112 - 113
  • [8] Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products
    Goldberger, David
    Vearrier, David
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 420 - 420
  • [9] Comment on: Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products
    Michael E. Mullins
    S. Eliza Dunn
    Journal of Medical Toxicology, 2018, 14 : 112 - 113
  • [10] Combination Products Regulation at the FDA
    Lauritsen, K. J.
    Nguyen, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) : 468 - 470
12345